Cancer-fighting Technology Developed at UCF Licensed to French Pharmaceutical Giant
One of the biggest pharma companies in the world will use a nanoparticle technology developed at UCF in hopes of coming up with new blood cancer treatments.
In May, a cell-based cancer immunotherapy that utilizes a nanoparticle developed at UCF to stimulate a patient’s natural cancer-killing cells headed to Phase II clinical trial.
College of Medicine Associate Professor Alicja Copik and her team developed the technique in 2016 and then co-founded the company CytoSen to take the concept to market. In 2019, the company was acquired by Netherlands-based bio-pharmaceutical firm Kiadis Pharma, which saw the potential to develop new treatment options for cancer patients.
Last week, Kiadis licensed a bundle of technologies – including the one developed at UCF – to Sanofi in a deal estimated at about $1 billion. If the technologies advance through clinical trials and are approved, royalties would follow from commercial sales of products on the market.
Sanofi is based in France and employs more than 100,000 people in 100 countries. The company has 91 products in clinical trials. In 2019, it was ranked the eighth largest pharma company in the world based on sales of about $27.7 billion.
“The licensing of Kiadis’ CD38KO K-NK cells is particularly exciting for Sanofi since we will be studying this cell-based therapeutic with our recently FDA-approved treatment for patients with difficult-to-treat multiple myeloma, in hopes of bringing even more options to these patients with this hematologic cancer,” John Reed, the global head of research for Sanofi, says in a press release. “At Sanofi, we are committed to pioneering treatments that address unmet healthcare challenges. Innovative collaborations, such as this partnership with Kiadis, have the potential to expand the clinical benefits of our medicines by combining them with synergistic partnered therapeutics to deliver improved outcomes for patients.”
Natural killer (NK) cells are part of the body’s defense system and act as an army to protect us from invaders such as viruses and infections. Copik discovered a way to make NK cells even more powerful – by stimulating them with nanoparticles that multiply them and heighten their killing ability – and then use the cells to fight cancer. “That’s what it is all about,” she says, “giving patients a fighting chance of cancer survival.”
Copik’s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives. This is why universities invest in Technology Transfer Offices that help innovations get patented and licensed to industry. The commercialization process can take years.
“Our office is grateful to have the unique opportunity to partner with industry to bring the most promising technological advances developed by our dedicated researchers to market to impact global healthcare and improve quality of life,” says Svetlana Shtrom, UCF’s director of Office of Technology Transfer.
Share This Article
UCF Student Research Week 2023 Kicks Off with the Academic Exhibition of the Year
UCF students will share their findings with the university community during Student Research Week, March 27-31. Compiling and condensing all their work on one poster each, students will present their work...
UCF Graduate Dean’s Dissertation Completion Fellowship Drives Excellence, Provides Aid
As the cost of living has risen dramatically over the past several years, financial assistance has become a vital component of student success. There is no doubt that completing a...
UCF Postdoctoral Scholar Draws on Her Island Roots to Champion for Marginalized Populations
Makella Coudray is passionate about advocating for disadvantaged groups. “I personally like championing causes for those that society may overlook, and I try to do that through my work,” she...
UCF Researchers Work to Reduce the Amount of Precious Metals in Catalytic Converters
The precious metals, such as platinum, palladium and rhodium, in catalytic converters make the vehicle devices attractive to thieves, but University of Central Florida researchers are working to reduce the...
UCF Researcher Receives Samsung International Global Research Outreach Award
Debashis Chanda, a professor in UCF’s NanoScience Technology Center, recently received Samsung’s International Global Research Outreach Award for the year 2022 in the Future Camera and Sensor category. This is...